Lupin Gets New Drug Approval for Solosec from US Regulator
On Thursday, 1st July 2021, the pharmaceutical company ‘Lupin’ said, the company’s subsidiary based in the United States have received the approval from the health regulator of the United States of America for the company’s new supplemental drug application for the purpose of expanding the use of the drug ‘Solosec’ for the treatment of trichomoniasis, […]
Continue Reading